Activity Dates: 04/22/2013 - 04/22/2016
This course is closed. Please look for other available products in CPNP University.
If you are a pharmacist, nurse practitioner or other healthcare professional involved in the comprehensive medication management of psychiatric and/or neurological patients, we invite you to participate in this online course.
Schizoaffective disorder (SZA), since its introduction 80 years ago, has raised considerable controversy regarding its distinction from schizophrenia and mood disorders, as well as its validity as an independent diagnostic category. DSM-IV-TR allows diagnosis of SZA based upon a current episode of illness, leading to its common use in acute care settings. The proposed changes in DSM-5 for SZA will require consideration of the lifetime of illness, which will significantly reduce the prevalence of SZA. The most consistent findings in SZA literature are that SZA is often used incorrectly by clinicians, and SZA has very low diagnostic reliability over time. Increasing evidence that schizophrenia and bipolar disorder share genetic mechanisms creates further uncertainty about the diagnosis of SZA. An evidence-based approach to the treatment of SZA is not feasible since so few studies have been done to specifically evaluate antipsychotics, mood stabilizers, antidepressants, and their combinations. Rather, treatment must rely on the evidence base established for the treatment of schizophrenia, bipolar disorder, and depression with treatment decisions guided by presenting symptoms. Because a diagnosis of SZA requires meeting criteria for schizophrenia, antipsychotic drugs are the primary treatment for SZA. Recommendations for acute treatment of SZA bipolar type is an antipsychotic drug, with a mood stabilizer added for depressive symptoms, while maintenance treatment is an atypical antipsychotic alone or in combination with a mood stabilizer. Treatment of SZA depressive type has virtually no literature basis, but an antipsychotic plus antidepressant, or antipsychotic plus a mood stabilizer is recommended.
You will proceed through the following steps to satisfactorily complete this course:
This course is provided online at cpnp.org and consists of the speaker audio and slides. A PDF file of the slides is also provided and access is available to participants indefinitely although ACPE credit is available only through the course expiration date.
Participants in this course must complete an examination and achieve a score of 60% or greater. Successful completion of the course also requires the completion of a course evaluation. ACPE statements of credit can be retrieved by participants online at cpnp.org immediately upon successful completion of the course.
CPNP has invested in supporting the most popular web browsers and leveraging software that our members use daily. Beyond PDF downloads, the rest of the system is built on HTML5, a technology that most up-to-date browsers will support. To access CPNP course materials online, you will need:
CPNP web sites no longer fully support Microsoft Internet Explorer 9 and older or Windows Vista and older. We cannot guarantee that the site will function perfectly on every device and configuration, but using the latest version of the software above will greatly improve your experience.
Glen Stimmel, PharmD, BCPP
View biographical information and disclosuresThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This self-study course provides 1.0 contact hours (0.01 CEUs) of knowledge-based continuing education credit from CPNP approved programming. The ACPE universal program number assigned to this course is 0284-000-13-008-L01-P (1.0 contact hours).
ACPE approved contact hours are accepted for ANCC Certification Renewal (see pages 5 and 6): At least 50% (37.5 hours) of your 75 continuing education hours must be formally approved continuing education hours. Formally approved continuing education hours meet one or more of the criteria listed below:
2013 CPNP Program Committee
Disclosures of Interest
Name | Disclosures of Interest |
---|---|
Jennifer Bean, PharmD, BCPS, BCPP |
Employment: VA-Tennessee Valley Healthcare System, Clinical Pharmacy Specialist, University of Tennessee, College of Pharmacy Assistant Professor without Tenure Educational Grants, Research Grants or Contracts: American Society of Health System, Federal Grant Co-Investigator |
Jacquelyn Canning, PharmD, BCPP Assistant Professor Albany College of Pharmacy and Health Sciences Albany, NY |
Employment: Albany College of Pharmacy and Health Sciences Department of Pharmacy Practice Assistant Professor, Stratton VA Medical Center |
Marshall Cates, PharmD, BCPP, FASHP Professor of Pharmacy Practice Samford University McWhorter School of Pharmacy Birmingham, AL | No Relevant Financial Relationships to Disclose |
Jessica Cather, PharmD, BCPP, BCPS |
No Relevant Financial Relationships to Disclose |
Jack Chen, PharmD, BCPS, CGP, FASCP, FCCP Associate Professor Loma Linda University Loma Linda, CA |
External Consultant Activities, Advisory Panels, Speakers Bureaus, etc.: Chelsea Pharmaceuticals - Consultant, Ipsen - Consultant, Teva Neuroscience - Consultant |
Lara Frick, PharmD, BCPP, BCPS, CGP No work info on profile Gilbert, AZ |
Employment: St. Luke's Behavioral Health Center, Assistant Director of Pharmacy External Consultant Activities, Advisory Panels, Speakers Bureaus, etc.: Adjunct Faculty, A.T. Still School of Osteopathic Medicine in Arizona Educational Grants, Research Grants or Contracts: Josiah Macy Foundation, grant for interprofessional education |
Deanna Kelly, PharmD, BCPP Professor University of Maryland Baltimore, MD |
Employment: University of Maryland School of Medicine Educational Grants, Research Grants or Contracts: Bristol Myers Squibb/Otsuka, Janssen Pharmaceutica, Ameritox, Ltd |
Amy Lovell, PharmD Research Scientist, Mental Health Outcomes University of Kentucky College of Pharmacy Lexington, KY |
Employment: University of Kentucky Institute for Pharmaceutical Outcomes and Policy, Lexington, Ky Research Scientist and Project Manager, Saint Joseph Hospital East, Lexington, Ky, Pharmacist Educational Grants, Research Grants or Contracts: Department for Behavioral Health and Developmental and Intellectual Disabilities, Kentucky Cabinet for Health and Family Services |
Jodie V. Malhotra, PharmD |
No Relevant Financial Relationships to Disclose |
Troy A. Moore, PharmD, BCPP, MS Clinical Pharmacy Specialist/Assistant Professor STVHCS/University of Texas HSC San Antonio San Antonio, TX |
Employment: South Texas Veterans Health Care System, Clinical Pharmacy Specialist- Psychiatry, University of Texas Health Science Center at San Antonio, Assistant Professor External Consultant Activities, Advisory Panels, Speakers Bureaus, etc.: Planning committee for the University of Texas College of Pharmacy Psychopharmacology Update |
Gerald P. Overman, PharmD, BCPP Clinical Pharmacy Specialist, NIMH National Institutes of Health Bethesda, MD |
No Relevant Financial Relationships to Disclose |
Sarah Popish, PharmD, BCPP Academic Educator Department of Veterans Affairs Vallejo, CA |
No Relevant Financial Relationships to Disclose |
Jill Reynoldson, PharmD, BCPP |
No Relevant Financial Relationships to Disclose |
Tawny Smith, PharmD, BCPP |
No Relevant Financial Relationships to Disclose |
Christopher Thomas, PharmD, BCPP, BCPS, CGP |
Employment: Chillicothe VAMC (Clinical Pharmacist and Residency Program Director), Wife: Omnicare (Consultant/Clinical Pharmacist) Financial Interests: Omnicare, Pfizer, Merck, Glaxo, Lilly, Proctor and Gamble Stock |
2013 CPNP Recertification Editorial Board
Disclosures of Interest
Name | Disclosures of Interest |
---|---|
Sara Dugan, PharmD, BCPP Associate Professor Northeast Ohio Medical University College of Pharmacy and Medicine Rootstown, OH |
Employment: Northeast Ohio Medical University College of Pharmacy External Consultant Activities, Advisory Panels, Speakers Bureaus, etc.: Otsuka/Lundberg-CMHC Advisory Panel |
Jill Fowler, PharmD, MS, BCPP Clinical Pharmacy Specialist, Psychiatry University of Iowa Hospitals and Clinics Iowa City, IA |
No Relevant Financial Relationships to Disclose |
Beth Hall, PharmD, BCPP Director of Pharmacy Fulton State Hospital Fulton, MO |
Employment: Clinical Manager for Pharmacy Systems, Inc. placed at Fulton State Hospital External Consultant Activities, Advisory Panels, Speakers Bureaus, etc.: CPNP Review Course author/speaker |
Rania Kattura, PharmD, MS, BCPP |
Employment: University of Texas at Austin-College of Pharmacy; CVS/Pharmacy; float PRN staff pharmacist Non-Financial Interests: member of planning committee for the annual UTPsych Update conference in Austin, TX, Volunteer Pharmacist at free mental health clinic in Cedar Park, TX |
Cynthia Kirkwood, PharmD, BCPP Professor, Vice Chair for Education Virginia Commonwealth University Richmond, VA |
Employment: Virginia Commonwealth University, Professor of Pharmacy |
Susan Lakey, PharmD, MPH, BCPP Clinical Assistant Professor University of Washington Seattle, WA |
No Relevant Financial Relationships to Disclose |
Sarah Melton, PharmD, BCPP, BCACP, CGP, FASCP Associate Professor of Pharmacy Practice Gatton College of Pharmacy Johnson City, TN |
Employment: Gatton College of Pharmacy, East Tennessee State University, Associate Professor of Pharmacy Practice Non-Financial Interests: Virginia Foundation for Healthy Youth, One Care of Southwest Virginia |
Sudha Narayanaswamy, PharmD, BCPP |
Employment: GNYHA Services, Inc., Assistant Vice President, Clinical Pharmacy Program External Consultant Activities, Advisory Panels, Speakers Bureaus, etc.: Pharmacy Consultant for Hemodialysis at a hospital in NJ; General Advisory Board, My Gateway to Overcoming Autism in Life, MyGoal, Inc |
Susie Park, PharmD, BCPP Assistant Professor University of Southern California Los Angeles, CA |
Employment: University of Southern California |
Craig Straley, PharmD, BCPP Professor of Pharmacy Practice Ferris State University Battle Creek, MI |
Financial Interests: Johnson and Johnson stock holdings, Pfizer, Inc. stock |
Off-Label Use: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA (see faculty information and disclosures). The opinions expressed in the educational activity do not necessarily represent the views of CPNP and any educational partners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Cyberonics
Lilly
This activity is supported by an educational grant from Lilly USA, LLC. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.